Boussard & Gavaudan Investment Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,052	Closed	-$875K	–	104
2023 Q3	$875K	Buy	+1,052	New	+$210K	0.1%	65

Other funds holding SGEN

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

FBC

Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

SAG

Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Boussard & Gavaudan Investment Management's SGEN Position: Q4 2023 in Review

Boussard & Gavaudan Investment Management sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 212,105 shares — an estimated $45.1M sold.

Boussard & Gavaudan Investment Management first reported a position in SGEN in Q2 2023 and held it in 2 quarters. The position peaked at $45.1M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

Boussard & Gavaudan Investment Management reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Boussard & Gavaudan Investment Management sold 212,105 Seagen Inc. Common Stock shares in Q4 2023, an estimated $45.1M.
Boussard & Gavaudan Investment Management first reported a position in Seagen Inc. Common Stock in Q2 2023 and held it in 2 quarters.
Boussard & Gavaudan Investment Management's Seagen Inc. Common Stock position peaked at $45.1M in Q3 2023.
6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.